Matches in Wikidata for { <http://www.wikidata.org/entity/Q38181289> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q38181289 description "article científic" @default.
- Q38181289 description "article scientifique" @default.
- Q38181289 description "articol științific" @default.
- Q38181289 description "articolo scientifico" @default.
- Q38181289 description "artigo científico" @default.
- Q38181289 description "artigo científico" @default.
- Q38181289 description "artigo científico" @default.
- Q38181289 description "artikel ilmiah" @default.
- Q38181289 description "artikull shkencor" @default.
- Q38181289 description "artículo científico" @default.
- Q38181289 description "artículu científicu espublizáu en 2014" @default.
- Q38181289 description "bilimsel makale" @default.
- Q38181289 description "scienca artikolo" @default.
- Q38181289 description "scientific article published on 07 January 2014" @default.
- Q38181289 description "scientific article published on 07 January 2014" @default.
- Q38181289 description "scientific article published on 07 January 2014" @default.
- Q38181289 description "vedecký článok" @default.
- Q38181289 description "vetenskaplig artikel" @default.
- Q38181289 description "videnskabelig artikel" @default.
- Q38181289 description "vitenskapelig artikkel" @default.
- Q38181289 description "vitskapeleg artikkel" @default.
- Q38181289 description "vědecký článek" @default.
- Q38181289 description "wetenschappelijk artikel" @default.
- Q38181289 description "wissenschaftlicher Artikel" @default.
- Q38181289 description "наукова стаття, опублікована в січні 2014" @default.
- Q38181289 description "научная статья" @default.
- Q38181289 description "научни чланак" @default.
- Q38181289 description "מאמר מדעי" @default.
- Q38181289 description "مقالة علمية نشرت في 07 يناير 2014" @default.
- Q38181289 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38181289 name "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 name "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 name "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 type Item @default.
- Q38181289 label "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 label "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 label "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 prefLabel "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 prefLabel "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 prefLabel "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature." @default.
- Q38181289 P1433 Q38181289-E0F56780-8B87-409A-83E9-EF1F6CE3094C @default.
- Q38181289 P1476 Q38181289-315BA8D5-1E80-4A8A-9A73-51A8B95794E0 @default.
- Q38181289 P2093 Q38181289-DC76BA28-B385-44F0-A5C8-5F7C732A7589 @default.
- Q38181289 P304 Q38181289-1A25AECD-265F-47DB-9532-EB1AECD92557 @default.
- Q38181289 P31 Q38181289-CEDA375D-2A5D-4284-9E45-DEB8865E7AEE @default.
- Q38181289 P356 Q38181289-1A8767DF-E7F9-4917-840F-3783F4B4B303 @default.
- Q38181289 P433 Q38181289-CAF5B625-5094-4744-95CD-4784D271931B @default.
- Q38181289 P478 Q38181289-33306D87-B202-4F65-890B-8F7825C72E5E @default.
- Q38181289 P50 Q38181289-C034CCCE-6571-45F1-A7C5-5A58B13D5265 @default.
- Q38181289 P577 Q38181289-5E4516AC-3D7E-4A10-BEF4-5A478E40D091 @default.
- Q38181289 P698 Q38181289-9984CA20-7B0F-4479-ACE8-BBD8F19A900E @default.
- Q38181289 P8608 Q38181289-EB16B1C6-182C-464F-A5EE-2C726447CD5D @default.
- Q38181289 P921 Q38181289-68BAE15F-0874-4648-9DFC-6017EDC6B1D9 @default.
- Q38181289 P921 Q38181289-BF59B83B-C92D-4E59-A56C-0CF39DA541FD @default.
- Q38181289 P356 J.CRITREVONC.2013.12.013 @default.
- Q38181289 P698 24457121 @default.
- Q38181289 P1433 Q15724423 @default.
- Q38181289 P1476 "Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature" @default.
- Q38181289 P2093 "Mona Fouad" @default.
- Q38181289 P304 "1-8" @default.
- Q38181289 P31 Q13442814 @default.
- Q38181289 P356 "10.1016/J.CRITREVONC.2013.12.013" @default.
- Q38181289 P433 "1" @default.
- Q38181289 P478 "91" @default.
- Q38181289 P50 Q48295470 @default.
- Q38181289 P577 "2014-01-07T00:00:00Z" @default.
- Q38181289 P698 "24457121" @default.
- Q38181289 P8608 "release_wi3p6vatbfd6foy2x4ydtk3x6m" @default.
- Q38181289 P921 Q1148337 @default.
- Q38181289 P921 Q1504425 @default.